Patient Support

Jaime and his son from Brazil, Primary Progressive Multiple Sclerosis
Jaime and his son from Brazil, Primary Progressive Multiple Sclerosis

Patient Community Charter

Our commitment to patients extends beyond developing therapies. We’re also here to help patients obtain access to treatment through a variety of programs and resources.

For patients in the U.S.

We understand obtaining access to treatment can be complicated. To help, we have remained committed to developing patient support services and programs that provide assistance, including:

  • Helping patients navigate the complexities of their insurance plans (both private and public)
  • Researching alternative forms of funding and reimbursement
  • Providing free or subsidized treatment for eligible patients with no other options
  • Access to educational resources and programs for patients to learn more about their disease and treatment
  • Assigning individual case managers who work one-on-one with qualified patients in the U.S. to help obtain ongoing access to treatment

Committed to maintaining this level of service, we continue to closely monitor the health care environment to understand how changes in public policy, the private insurance market, and other areas may affect patients.

Sanofi Patient Connection

Our passion is to improve access to medicines and healthcare. Sanofi Patient Connection is an access and support program in the U.S., providing medication at no cost to eligible patients, helping patients understand their insurance coverage, and identifying additional resources patients may find helpful.

Additional Support

Aldurazyme® (laronidase) support

ALPROLIX® [Coagulation Factor IX (Recombinant), FC Fusion Protein] support

ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] support

Cablivi® (caplacizumab-yhdp) support

CAPRELSA® (vandetanib) support

Cerdelga® (eliglustat) capsules support

Cerezyme® (imiglucerase) for injection support

DUPIXENT® (dupilumab) injection support

ELOCTATE® [Antihemophilic Factor (Recombinant), FC Fusion Protein] support

ENJAYMO® (sutimlimab-jome) injection for intravenous use support

Fabrazyme® (agalsidase beta) support

KEVZARA® (sarilumab) injection support

LEMTRADA® (alemtuzumab) support

Lumizyme® (alglucosidase alfa) support

MOZOBIL® (plerixafor) injection support

Multaq® (dronedarone) tablets support

Nexviazyme® (avalglucosidase alfa-ngpt) support

REZUROCK® (belumosudil) tablets support

Sarclisa® (isatuxamab-irfc) injection for Intravenous Use support

Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] support

Thyrogen® (thyrotropin alfa) support

TZIELD® (teplizumab-mzwv) injection support